Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH

J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / epidemiology
  • Clinical Decision-Making
  • Drug Interactions
  • Hemorrhage / chemically induced
  • Humans
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy*
  • Neoplasms / epidemiology
  • Patient Preference
  • Patient Safety
  • Patient Selection
  • Quality of Life
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antineoplastic Agents